Steven Cohen's BSX Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 2.43 M shares of Boston Scientific Corporation (BSX) worth $232.14 M, representing 0.26% of the portfolio. First purchased in 2014-Q3, this long-term strategic position has been held for 44 quarters.
Based on 13F filings since 2013, Steven Cohen has maintained a long-term strategic position in BSX, representing a significant commitment to this investment thesis. Largest addition occurred in Q3 2023, adding 2.93 M shares. Largest reduction occurred in Q1 2015, reducing 2.94 M shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Boston Scientific Corporation (BSX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Boston Scientific Corporation (BSX) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +803,510 | Add 49.26% | 2.43 M | $95.35 |
| Q3 2025 | -829,610 | Reduce 33.71% | 1.63 M | $97.63 |
| Q2 2025 | +580,128 | Add 30.85% | 2.46 M | $107.41 |
| Q1 2025 | -365,264 | Reduce 16.26% | 1.88 M | $100.88 |
| Q4 2024 | -1.14 M | Reduce 33.59% | 2.25 M | $89.32 |
| Q3 2024 | +256,797 | Add 8.22% | 3.38 M | $83.80 |
| Q2 2024 | +758,833 | Add 32.07% | 3.13 M | $77.01 |
| Q1 2024 | -2.34 M | Reduce 49.77% | 2.37 M | $68.49 |
| Q4 2023 | -1.71 M | Reduce 26.64% | 4.71 M | $57.81 |
| Q3 2023 | +2.93 M | Add 83.97% | 6.42 M | $52.80 |
| Q2 2023 | +1.71 M | Add 95.92% | 3.49 M | $54.09 |
| Q1 2023 | +1.58 M | Add 800.44% | 1.78 M | $50.03 |
| Q4 2022 | -2.73 M | Reduce 93.24% | 197,869 | $46.27 |
| Q3 2022 | +182,829 | Add 6.67% | 2.93 M | $38.73 |
| Q2 2022 | +22,144 | Add 0.81% | 2.74 M | $37.27 |
| Q1 2022 | +817,822 | Add 42.98% | 2.72 M | $44.29 |
| Q4 2021 | +817,400 | Add 75.30% | 1.9 M | $42.48 |
| Q3 2021 | +1.09 M | New Buy | 1.09 M | $43.39 |
| Q1 2021 | -95,000 | Sold Out | 0 | $0.00 |
| Q4 2020 | +47,140 | Add 98.50% | 95,000 | $35.95 |
| Q3 2020 | +47,860 | New Buy | 47,860 | $38.22 |
| Q1 2020 | -636,554 | Sold Out | 0 | $0.00 |
| Q4 2019 | +636,554 | New Buy | 636,554 | $45.22 |
| Q3 2019 | -48,807 | Sold Out | 0 | $0.00 |
| Q2 2019 | +38,135 | Add 357.34% | 48,807 | $42.99 |
| Q1 2019 | -137,040 | Reduce 92.78% | 10,672 | $38.42 |
| Q4 2018 | -2.91 M | Reduce 95.17% | 147,712 | $35.34 |
| Q3 2018 | +1.59 M | Add 108.26% | 3.06 M | $38.50 |
| Q2 2018 | +370,800 | Add 33.76% | 1.47 M | $32.70 |
| Q1 2018 | +1.1 M | New Buy | 1.1 M | $27.32 |
| Q4 2017 | -125,500 | Sold Out | 0 | $0.00 |
| Q3 2017 | -922,000 | Reduce 88.02% | 125,500 | $29.17 |
| Q2 2017 | +1.05 M | New Buy | 1.05 M | $27.72 |
| Q1 2017 | -358,400 | Sold Out | 0 | $0.00 |
| Q4 2016 | -1.26 M | Reduce 77.91% | 358,400 | $21.63 |
| Q3 2016 | -293,382 | Reduce 15.31% | 1.62 M | $23.80 |
| Q2 2016 | -749,618 | Reduce 28.12% | 1.92 M | $23.37 |
| Q1 2016 | +1.98 M | Add 286.15% | 2.67 M | $18.81 |
| Q4 2015 | -1.95 M | Reduce 73.84% | 690,300 | $18.44 |
| Q3 2015 | -152,100 | Reduce 5.45% | 2.64 M | $16.41 |
| Q2 2015 | +1.08 M | Add 63.60% | 2.79 M | $17.70 |
| Q1 2015 | -2.94 M | Reduce 63.29% | 1.71 M | $17.75 |
| Q4 2014 | +2.12 M | Add 84.14% | 4.65 M | $13.25 |
| Q3 2014 | +2.52 M | New Buy | 2.52 M | $11.81 |
Steven Cohen's Boston Scientific Corporation Investment FAQs
Steven Cohen first purchased Boston Scientific Corporation (BSX) in Q3 2014, acquiring 2,523,500 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Boston Scientific Corporation (BSX) for 44 quarters since Q3 2014.
Steven Cohen's largest addition to Boston Scientific Corporation (BSX) was in Q3 2023, adding 6,421,754 shares worth $339.07 M.
According to the latest 13F filing for Q4 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 2,434,563 shares of Boston Scientific Corporation (BSX), valued at approximately $232.14 M.
As of the Q4 2025 filing, Boston Scientific Corporation (BSX) represents approximately 0.26% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Boston Scientific Corporation (BSX) was 6,421,754 shares, as reported at the end of Q3 2023.